Management of atrial fibrillation in rheumatic valvular heart disease.
Atrial fibrillation in patients with rheumatic valvular heart disease results in significant morbidity and possibly mortality. The recent advances in treatment options for non-rheumatic atrial fibrillation have widened its scope of management. These treatment modalities have not been extensively validated in rheumatic valvular heart disease. A review and comparison of the available data in atrial fibrillation and rheumatic valvular heart disease vis-à-vis non-rheumatic atrial fibrillation is presented.